Skip to main content

Table 3 Comparison of Assessment Accuracy for VTE Development Among all Scores

From: Optimal authoritative risk assessment score of Cancer-associated venous thromboembolism for hospitalized medical patients with lung Cancer

Variables

Khorana

PROTECHT

CONKO

ONKOTEV

COMPASS-CAT

CATS/MICA

Sensitivity -%

72.8

76.9

75.1

81.5

79.8

38.1

Specificity -%

79.7

81.5

80.2

86.8

76.3

84.9

PPV -%

36.3

39.7

37.6

49.5

53.5

28.6

NPV -%

94.9

95.7

85.9

96.7

96.0

89.6

FPR -%

20.3

18.5

19.8

13.2

23.7

15.1

FNR -%

27.2

23.1

24.9

18.5

20.2

61.8

PLR

3.59

4.16

3.79

6.17

3.37

2.52

NLR

0.34

0.28

0.31

0.21

0.27

0.73

DOR

10.5

14.7

12.2

29.0

12.7

3.5

CA -%

78.8

80.1

79.5

86.1

76.8

78.5

AA -%

70.9

73.4

72.1

78.6

71.7

60.3

YI

0.53

0.58

0.55

0.68

0.56

0.23

  1. Note: PPV: Positive Predictive Value, NPV: Negative Predictive Value, FPR: False Positive Rate, FNR: False Negative Rate, PLR: Positive Likelihood Ratio, NLR: Negative Likelihood Ratio, DOR: Diagnostic Odds Ratio, CA: Crude Agreement, AA: Adjusted Agreement, YI: Youden Index